SudingPN, OrricoRP, JohnsonSB, WilsonSE. Concordance of interrater assessments of surgical methods to achieve source control of intra-abdominal infections. Am J Surg, 2008; 196:70–73.
2.
PassarellJA, MeagherAK, LioliosKet al.Exposure–response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections. Antimicrob Agents Chemother, 2008; 52:204–210.
3.
BetriuC, Rodriguez-AvialI, GómezMet al.Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centres: Second multicenter study. Diagn Microbiol Infect Dis, 2006; 56:437–444.
4.
OlivaME, RekhaA, YellinAet al.A multicenter trial of the efiicacy and safety of tygecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections. BMC Infect Dis, 2005; 19:88.
5.
BarberánJ, MensaJ, FariñasCet al.Recomendaciones de tratamiento antibiótico en pacientes alérgicos a beta-lactámicos. Rev Esp Quimioter, 2008; 21:60–82.
